Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
 |
2023 –2030 |
 |
USD 1.28 Billion |
 |
USD 2.17 Billion |
 |
% |
|
|
Global Oxytocin Injection Market, By Type (Branded, Generic), Application (Incomplete Abortion, Pregnancy loss, Bleeding Control, Parturition, Contraction Stress Test, Psychiatric Disorders, Lactation Control), Organism Type (Human, Animal), Sex (Men, Women), Route of Administration (Intranasal, Intravenously, Intramuscular), End-Users (Clinics, Hospitals, Birth Center, Mental Health Facility), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
According to "National Vital Statistics Reports," which were published in February 2022, the percentage of unmarried births in 2020 varied from almost one in five in Utah (19.3%) to more than one in two in Louisiana (54.5%), Mississippi (55.8%), and New Mexico (53.2%). As a result, it is anticipated that the varying birth demographics in the various areas of North America will drive market expansion throughout the forecast period.
Data Bridge Market Research analyses that the oxytocin injection market, which was USD 1.28 billion in 2022, is expected to reach USD 2.17 billion by 2030, at a CAGR of 6.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Branded, Generic), Application (Incomplete Abortion, Pregnancy loss, Bleeding Control, Parturition, Contraction Stress Test, Psychiatric Disorders, Lactation Control), Organism Type (Human, Animal), Sex (Men, Women), Route of Administration (Intranasal, Intravenously, Intramuscular), End-Users (Clinics, Hospitals, Birth Center, Mental Health Facility), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Bimeda, Inc. (Ireland), Grindeks (Latvia), KAPL (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), AnkeBio Co., Ltd (China), Aspen Veterinary Resources, LTD (U.S.), Hemmo Pharmaceuticals Pvt Ltd (India), Shenzhen JYMed Technology Co., Ltd (China), Systacare Remedies (U.S.), AdvaCare Pharma (India), Sundent Pharm Group (Netherlands), Fresenius Kabi USA (U.S.), SAINTROY LIFESCIENCE (India), Sri Pharmacare (India)
|
|
Market Opportunities
|
|
Market Definition
Oxytocin injection is used to initiate or intensify labor contractions. Oxytocin is also used to lessen postpartum hemorrhage. Moreover, it could be combined with other treatments or drugs to end a pregnancy. Since oxytocin is commonly used for parturition and lactation, it is also used for abrupt deliveries. It is possible to administer oxytocin injections intravenously, intramuscularly, and intranasal.
Drivers
Global birth rates are rising, more pregnancies are ending in problems, and people are becoming more aware of induced labor and nursing. For instance, the United Nations International Children's Emergency Fund (UNICEF) reported in its December 2021 update that an anticipated 140 million children were born in 2021. In addition, the International Institute for Sustainable Development's August 2021 report projects that by 2050, there will be 9.7 billion people on the planet. This amount indicates an increase of over 24% from 2020. Since oxytocin is recommended for antepartum and postpartum pregnancies, there is a significant likelihood that the market for this injection will expand due to the increased birth rate and population.
Oxytocin-related innovations and joint ventures contribute to the market's expansion. For instance, according to the January 2021 update, Tonix Pharmaceuticals and Katana Pharmaceuticals have a licensing deal for Tonix's intranasal potentiated oxytocin. This will increase drug usage in metabolic disorders, particularly insulin resistance, diabetes, and obesity. Preclinical data show the efficacy of the intranasal oxytocin product TNX-1900 in central nervous system disorders, with migraine chosen by Tonix as the lead indication. The licensing agreement adds to the company's initial purchase of oxytocin-potentiated therapy from Trigemina in June 2020. These oxytocin-related joint ventures and alliances pave the way for several indications, fostering the market's expansion during the forecast period.
Opportunities
The use of oxytocin in the area of pregnancy aids market expansion. For instance, according to the article titled "Role of Oxytocin in Prevention of Postpartum Hemorrhage in Unplanned Out-of-Hospital Deliveries Treated by Emergency Medical Services," published in July 2020, in Finland, postpartum hemorrhage following unplanned out-of-hospital deliveries was prevented by administering intramuscular or intravenous oxytocin. The primary factors influencing the growth of the oxytocin injection market include rising disposable incomes, particularly in developing nations, rising awareness among women about pregnancy care products, an increase in women's literacy rates, and an increase in the number of well-developed distribution channels for oxytocin products. These are certain factors that act as an immense opportunity.
Restraints/Challenges
Side effects associated with oxytocin injection include fast, slow, or blurred vision, uneven heart rate, severe headache, excessive bleeding long after childbirth, pounding in your neck or ears or confusion, severe weakness, and feeling unsteady. These all hamper the market growth.
This oxytocin injection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oxytocin injection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
The oxytocin injection market is segmented on the basis of type, application, organism type, sex, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Application
Organism Type
Sex
Route of Administration
End-Users
Distribution Channel
The oxytocin injection market is analysed and market size insights and trends are provided by country, type, application, organism type, sex, route of administration, end-users and distribution channel as referenced above.
The countries covered in the oxytocin injection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the oxytocin injection market due to the high cost of healthcare and favorable reimbursement regulations for oxytocin injections.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the steady rise in the number of births and women's growing understanding of reproductive health.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The oxytocin injection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oxytocin injection market.
Some of the major players operating in the oxytocin injection market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
The market is segmented based on , By Type (Branded, Generic), Application (Incomplete Abortion, Pregnancy loss, Bleeding Control, Parturition, Contraction Stress Test, Psychiatric Disorders, Lactation Control), Organism Type (Human, Animal), Sex (Men, Women), Route of Administration (Intranasal, Intravenously, Intramuscular), End-Users (Clinics, Hospitals, Birth Center, Mental Health Facility), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030. .
The Global Oxytocin Injection Market size was valued at USD 1.28 USD Billion in 2022.
The Global Oxytocin Injection Market is projected to grow at a CAGR of 6.8% during the forecast period of 2023 to 2030.
The major players operating in the market include BimedaInc. , Grindeks , KAPL , Novartis AG , Pfizer Inc. , AnkeBio Co.Ltd , Aspen Veterinary ResourcesLtd , Hemmo Pharmaceuticals Pvt Ltd , Shenzhen JYMed Technology Co.Ltd , Systacare Remedies , AdvaCare Pharma , Sundent Pharm Group , Fresenius Kabi USA , SAINTROY LIFESCIENCE , Sri Pharmacare .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
